Concepedia

Samuel Y. Ng

SY

Statistics

Publications

28

Citations

2.5K

H-Index

19

Active since

1998

Affiliations

Dana-Farber Cancer Institute(Current)

Massachusetts General Hospital

Harvard University

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

Samuel Y. Ng is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1998–2024

28

Publications

28

Early hematopoietic lineage restrictions directed by Ikaros

Toshimi Yoshida, Samuel Y. Ng, Juan Carlos Zúñiga‐Pflücker et al. · Nature Immunology · 2006 · 310 citations · Full text

Life Sciences, Cell Biology, Hematology +10

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 304 citations · Full text

Medicine, Biomedical Sciences, Drug Discovery +6

Genome-wide Lineage-Specific Transcriptional Networks Underscore Ikaros-Dependent Lymphoid Priming in Hematopoietic Stem Cells

Samuel Y. Ng, Toshimi Yoshida, Jiangwen Zhang et al. · Immunity · 2009 · 243 citations · Full text

Life Sciences, Hematology, Molecular Biology +12

Death-effector Filaments: Novel Cytoplasmic Structures that Recruit Caspases and Trigger Apoptosis

Richard M. Siegel, Lixin Zheng, Samuel Y. Ng et al. · The Journal of Cell Biology · 1998 · 236 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Philippe Armand, Yi‐Bin Chen, Robert Redd et al. · Blood · 2019 · 186 citations · Full text

Life Sciences, Immunology, Oncology +16

1–5 of 28